14170 Semaglutide for Sale
Compare supplier listings for Semaglutide (CAS 2924330-56-1) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Factory OEM Weight Loss High Quality 99% Semaglutide 15mg 20mg 30mg per vial
-
Price:
$30-35/UNIT FOB
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial, 10vials/box
Tirzepatide,Semaglutide,Retatrutide
Semaglutide 10mg/30mg Obesity treatment Highly rated 100% return rate
-
Price:
$30-35/UNIT FOB
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10 mg per vial, 10vials/box
Tirzepatide,Semaglutide,Retatrutide
High Purity Low Price 99% Factory supply Pure Alprostadil powder
-
Price:
$4/G FOB
-
CAS No.:
745-65-3
-
Grade:
Pharmaceutical Grade
-
Content:
99.9%
-
Packaging:
0.05kg
Cosmetic Peptides 99% Purity Raw Lyophilized Powder Ara-290 Peptide Vial Peptide
-
Price:
$4/G FOB
-
CAS No.:
1208243-50-8
-
Grade:
Pharmaceutical Grade
-
Content:
99.9%
-
Packaging:
0.05kg
Semaglutide High-Purity Empowering Advanced CAS 910463-68-2 Weight Loss Peptide
-
Price:
$45/UNIT FOB
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg 10mg 15mg 20mg 30mg/vial,10vials/box
Products You May Be Interested in
GLP-1 cagrilintide Semaglutide Tirzepatide Retatrutide High Quality High Purity 99% peptides
-
Price:
$30-35/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg 10mg 15mg 20mg 30mg 40mg 50mg 60mg/ vial ,10vials/box
Best Weight Loss Peptides Semaglutide 99%Purity Hot selling in stock CAS: 910463-68-2
-
Price:
$35-40/G FOB
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10mg/vial,10vials/box
peptide
TR60 COA
Semaglutide SM02 High purity High Efficiency Factory direct
-
Price:
Price on request
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
20mg/vial
Semaglutide Bulk Peptide Material with Quality Documentation Support CAS 910463-68-2
-
Price:
$55/G FOB
-
CAS No.:
910463-68-2
-
Grade:
Reagent Grade
-
Content:
99%
-
Packaging:
1 g/bottle, 5 g/bottle, 10 g/bottle; customized gram-scale and bulk packaging available.
Retatrutide,Semaglutide,Tirzepatide,Cagrilintide,Cosmetic Peptides
Semaglutide Research Peptide Material for Biotechnology Development Projects CAS 910463-68-2
-
Price:
$55/G FOB
-
CAS No.:
910463-68-2
-
Grade:
Reagent Grade
-
Content:
99%
-
Packaging:
1 g/bottle, 5 g/bottle, 10 g/bottle; customized gram-scale and bulk packaging available.
Retatrutide,Semaglutide,Tirzepatide,Cagrilintide,Cosmetic Peptides
- Buying Semaglutide on www.echemi.com where you will find large variety of good choices. ECHEMI emphasizes on verifying suppliers of Semaglutide who have registered on the platform to ensure the accuracy and reliability of suppliers. Safe transaction of chemical will be made based on true information. Buy Semaglutide with 70000+ customers on ECHEMI and make orders now.
- We guarantee the quality of Semaglutide 2924330-56-1 on ECHEMI. Partners on ECHEMI are all selected in certification, qualification or scale. We help buyers to get Semaglutide with various requirement and regulations in global countries and regions. Further services on the whole supply chain can be provided with ECHEMI.
- We are providing better products and services of Semaglutide with fair price and reasonable deal. Member registered on ECHEMI will enjoy services of Semaglutide for example market price and insights and trade data. Efficient order options is the key for supply chain services we offer for you. Buyers are getting help to grow their business internationally on buying Semaglutide.
- •After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
- •The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
- •Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
- •Torrent Pharma Targets First Wave Semaglutide Launch Revenue Up 11 Percent as Patent Ends
- •New Trial Shows 62 Percent MASH Reversal with Semaglutide as $32 Billion Market Heats Up